MR imaging assessment of experimental hepatic dysfunction with mn‐DPDP
- 1 January 1995
- journal article
- research article
- Published by Wiley in Journal of Magnetic Resonance Imaging
- Vol. 5 (1), 11-16
- https://doi.org/10.1002/jmri.1880050105
Abstract
Manganese (II) N, N'‐dipyridoxylethylenediamine‐N, N'‐diacetate 5,5′‐bis(phosphate) (DPDP) is a paramagnetic magnetic resonance (MR) contrast agent that enhances the liver and is predominantly excreted through the biliary tree. The authors evaluated its utility in diffuse liver disease by assessing liver and gallbladder enhancement in 24 rabbits. Total (n = 6) or segmental (n = 6) biliary occlusion or galactosamine‐induced hepatitis (n = 6) was induced 3 days before imaging. Six rabbits served as normal controls. T1‐ and T2‐weighted axial MR images were acquired at baseline, followed by T1‐weighted images every 10 minutes for 1 hour after the intravenous administration of 20 μmol/kg Mn‐DPDP. Except for the segmental occlusion group, the baseline study did not allow distinction between normal and abnormal livers. The temporal hepatic enhancement pattern was statistically different for each group. The normal, segmental occlusion, and hepatitis groups showed patterns similar to one another but markedly higher signal intensity than the total‐occlusion group throughout the observation period. In contrast, the gallbladder showed a greater difference in both degree of enhancement and time to peak enhancement among the four groups. Mn‐DPDP produces a temporal hepatic enhancement pattern that allows recognition of markedly impaired livers, and gallbladder enhancement patterns that allow distinction of more subtly impaired livers.Keywords
This publication has 15 references indexed in Scilit:
- Hepatic MR imaging with Mn-DPDP: safety, image quality, and sensitivity.Radiology, 1992
- Focal liver lesions: MR imaging with Mn-DPDP--initial clinical results in 40 patients.Radiology, 1992
- Manganese-DPDP as a Hepatobiliary Contrast Agent in the Magnetic Resonance Imaging of Liver Tumors: Results of Clinical Phase II Trials in Germany Including 141 PatientsInvestigative Radiology, 1991
- Manganese Dipyridoxyl DiphosphateInvestigative Radiology, 1991
- Hepatobiliary MR imaging: first human experience with MnDPDP.Radiology, 1991
- Preclinical evaluation of MnDPDP: new paramagnetic hepatobiliary contrast agent for MR imaging.Radiology, 1991
- Assessment of the biliary tract after liver transplantation: T tube cholangiography or IODIDA scanningBritish Journal of Surgery, 1990
- MRI Contrast Media for the LiverInvestigative Radiology, 1990
- DISIDA kinetics measure liver function in dogsNuclear Medicine Communications, 1989
- Studies of Tissue NMR Relaxation Enhancement by ManganeseInvestigative Radiology, 1984